102 related articles for article (PubMed ID: 12808146)
1. Direct activation of the apoptosis machinery as a mechanism to target cancer cells.
Nguyen JT; Wells JA
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7533-8. PubMed ID: 12808146
[TBL] [Abstract][Full Text] [Related]
2. Defective cytochrome c-dependent caspase activation in ovarian cancer cell lines due to diminished or absent apoptotic protease activating factor-1 activity.
Wolf BB; Schuler M; Li W; Eggers-Sedlet B; Lee W; Tailor P; Fitzgerald P; Mills GB; Green DR
J Biol Chem; 2001 Sep; 276(36):34244-51. PubMed ID: 11429402
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta(1) induces apoptosis in rat FaO hepatoma cells via cytochrome c release and oligomerization of Apaf-1 to form a approximately 700-kd apoptosome caspase-processing complex.
Freathy C; Brown DG; Roberts RA; Cain K
Hepatology; 2000 Oct; 32(4 Pt 1):750-60. PubMed ID: 11003619
[TBL] [Abstract][Full Text] [Related]
4. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide.
Yang L; Mashima T; Sato S; Mochizuki M; Sakamoto H; Yamori T; Oh-Hara T; Tsuruo T
Cancer Res; 2003 Feb; 63(4):831-7. PubMed ID: 12591734
[TBL] [Abstract][Full Text] [Related]
5. A novel Apaf-1-independent putative caspase-2 activation complex.
Read SH; Baliga BC; Ekert PG; Vaux DL; Kumar S
J Cell Biol; 2002 Dec; 159(5):739-45. PubMed ID: 12460989
[TBL] [Abstract][Full Text] [Related]
6. Apaf-1 protein deficiency confers resistance to cytochrome c-dependent apoptosis in human leukemic cells.
Jia L; Srinivasula SM; Liu FT; Newland AC; Fernandes-Alnemri T; Alnemri ES; Kelsey SM
Blood; 2001 Jul; 98(2):414-21. PubMed ID: 11435311
[TBL] [Abstract][Full Text] [Related]
7. Dysfunctional apoptosome activation in ovarian cancer: implications for chemoresistance.
Liu JR; Opipari AW; Tan L; Jiang Y; Zhang Y; Tang H; Nuñez G
Cancer Res; 2002 Feb; 62(3):924-31. PubMed ID: 11830553
[TBL] [Abstract][Full Text] [Related]
8. Targeting the apoptosome for cancer therapy.
Ledgerwood EC; Morison IM
Clin Cancer Res; 2009 Jan; 15(2):420-4. PubMed ID: 19147745
[TBL] [Abstract][Full Text] [Related]
9. Nucleotide requirements for the in vitro activation of the apoptosis protein-activating factor-1-mediated caspase pathway.
Genini D; Budihardjo I; Plunkett W; Wang X; Carrera CJ; Cottam HB; Carson DA; Leoni LM
J Biol Chem; 2000 Jan; 275(1):29-34. PubMed ID: 10617581
[TBL] [Abstract][Full Text] [Related]
10. Apaf-1XL is an inactive isoform compared with Apaf-1L.
Fu WN; Kelsey SM; Newland AC; Jia L
Biochem Biophys Res Commun; 2001 Mar; 282(1):268-72. PubMed ID: 11264002
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis. A cinderella caspase takes center stage.
Kumar S; Vaux DL
Science; 2002 Aug; 297(5585):1290-1. PubMed ID: 12193776
[No Abstract] [Full Text] [Related]
12. Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization.
Lassus P; Opitz-Araya X; Lazebnik Y
Science; 2002 Aug; 297(5585):1352-4. PubMed ID: 12193789
[TBL] [Abstract][Full Text] [Related]
13. Apoptosome dysfunction in human cancer.
Hajra KM; Liu JR
Apoptosis; 2004 Nov; 9(6):691-704. PubMed ID: 15505412
[TBL] [Abstract][Full Text] [Related]
14. Apo cytochrome c inhibits caspases by preventing apoptosome formation.
Martin AG; Nguyen J; Wells JA; Fearnhead HO
Biochem Biophys Res Commun; 2004 Jul; 319(3):944-50. PubMed ID: 15184073
[TBL] [Abstract][Full Text] [Related]
15. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
Alas S; Ng CP; Bonavida B
Clin Cancer Res; 2002 Mar; 8(3):836-45. PubMed ID: 11895917
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic and autophagic cell death induced by histone deacetylase inhibitors.
Shao Y; Gao Z; Marks PA; Jiang X
Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18030-5. PubMed ID: 15596714
[TBL] [Abstract][Full Text] [Related]
17. Induction of an apoptotic program in cell-free extracts by 2-chloro-2'-deoxyadenosine 5'-triphosphate and cytochrome c.
Leoni LM; Chao Q; Cottam HB; Genini D; Rosenbach M; Carrera CJ; Budihardjo I; Wang X; Carson DA
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9567-71. PubMed ID: 9689121
[TBL] [Abstract][Full Text] [Related]
18. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs.
Tamm I; Wang Y; Sausville E; Scudiero DA; Vigna N; Oltersdorf T; Reed JC
Cancer Res; 1998 Dec; 58(23):5315-20. PubMed ID: 9850056
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCI-H460.
Huisman C; Ferreira CG; Bröker LE; Rodriguez JA; Smit EF; Postmus PE; Kruyt FA; Giaccone G
Clin Cancer Res; 2002 Feb; 8(2):596-606. PubMed ID: 11839682
[TBL] [Abstract][Full Text] [Related]
20. Role of Smac in human leukaemic cell apoptosis and proliferation.
Jia L; Patwari Y; Kelsey SM; Srinivasula SM; Agrawal SG; Alnemri ES; Newland AC
Oncogene; 2003 Mar; 22(11):1589-99. PubMed ID: 12642862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
